Whey from 17 women (four acutely infected with Toxoplasma gondii, eight chronically infected, and five uninfected) was studied. T. gondii-specific secretory IgA antibodies were demonstrated by ELISA in whey from acutely infected and one of eight chronically infected women. Such antibodies to tachyzoite proteins of < 14, 22, 26-28, 30, 46, 60, 70-80, and > (J. Clin. Invest. 1992.90:2585-2592
Introduction
Toxoplasma gondii can cause death, systemic illness, and loss of sight, hearing, cognitive, or other neurological function when it is acquired congenitally or in immunocompromised individuals ( 1, 2) . One strategy for development of protective preparations against organisms that initially infect via the intestine has been to stimulate intestinal, organism-specific secretory IgA (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . As T. gondii is initially acquired perorally ( 1 ), we studied whether humans produced such T. gondii-specific secretory IgA. Milk was used as the source ofthe secretory IgA. Epitopes recognized by such IgA then were characterized and the effect of this secretory IgA on infection of enterocytes in vitro was determined.
Methods
Collection of milk samples. Milk samples were obtained from 17 women. Serologic tests were performed by Dr. Jack Remington's laboratory (Stanford University and Palo Alto Medical Research Institute, Palo Alto, CA) as described ( 1, 2) . Serologic test results for these women are in Table I . Five were uninfected (i.e., T. gondii seronegative in the Sabin Feldman Dye test [negative] ); seven were chronically infected (i.e., T. gondii IgG seropositive, but IgM seronegative in the double sandwich IgM ELISA [chronic]); one had been infected periconceptually although serologic tests retained an acute pattern at the time her milk was obtained (subacute); and four were acutely infected (i.e., T. gondii IgM seropositive and AC/HS (a differential agglutination test) acute and three of these were mothers of a congenitally infected infants [acute] ). Milk samples were obtained according to National Institutes of Health guidelines concerning human subjects. Milk samples were collected by the women through manual expression and were immediately frozen at -20'C. Before analyses, samples were centrifuged at 10,000 g for 1 h to remove lipids. The clear middle layer was collected. Samples were divided into separate aliquots and stored at -I350C until analyzed. The studies described herein were performed within 1 yr of collection of the milk samples.
Preparation of T. gondii antigen for ELISA. Swiss Webster (SW) female mice (Harlan Sprague Dawley, Inc., Indianapolis, IN) that weighed 18-20 g were used. 2 X 107 RH strain tachyzoites in 0.2 ml isotonic saline were injected intraperitoneally into Swiss Webster mice. 2 d later, 5 ml of isotonic PBS, pH 7.4, was injected into the peritoneal cavity and the ascites-PBS suspension containing the parasite was aspirated. This suspension was forced through a 27-gauge needle to disrupt infected peritoneal exudate cells and filtered through a funnel lined with glass wool. It was then passed through a polycarbonate membrane filter with a 3-;tm pore diameter (Nuclepore Corp., Pleasanton, CA) to remove host cells. The filtered parasites were washed three times in PBS and centrifuged at 400 g for 15 min at 40C and were resuspended in distilled water at a concentration of 5 x 108/ml; they were then sonicated three times for 30 s each time, and centrifuged at 10,000 g for 15 min at 40C to remove cellular debris. The concentration of the soluble T. gondii lysate antigen was determined by the Lowry method (20) .
T. gondii-specific sIgA ELISA. Wells of polystyrene microtiter plates (Dynatech Laboratories, Inc., Chantilly, VA) were coated with 100 ,1 T. gondii lysate antigen (50 ,ug/ml) in 0.1 M carbonate buffer, pH 9.6. After an overnight incubation at 4°C, the plates were washed three times with 0.1 M PBS containing 0.5% Tween 20 (Sigma Chemical Co., St. Louis, MO), pH 7.2 (PBS-T), and postcoated with 4% bovine serum albumin, fraction V (Calbiochem Corp., La Jolla, CA) in PBS (PBS-B) for 1 h at 37°C. 100 !d of twofold serial dilutions of the whey samples in PBS-TB was added to each well. The plates were incubated for 1 h at 37°C followed by three washes in PBS-T. 100 /d of alkaline phosphatase-conjugated goat anti-human secretory IgA (Cappel Laboratories, West Chester, PA) diluted in PBS-TB was added to each well. The plates were incubated for 1 h at 37°C followed by three washes in PBS-T. 100 ,l of nitrophenyl phosphate (1 mg/ml; Sigma Chemical Co.) diluted in 0.05 M carbonate buffer, pH 9.6, was added to each well followed by an incubation for 1 h at 37°C, and the To prepare tachyzoites for in vitro challenge, infected monolayers were scraped with a rubber policeman to dislodge free tachyzoites and infected cells. The suspension was passed through a 27-gauge needle and a funnel lined with glass wool and was filtered free of host cells as described (23) . The tachyzoites were centrifuged at 400 g at 20C for 15 min. The pellet then was resuspended in 1 ml of Medium 199 (Gibco Laboratories) that contained 1.0% glutamine, 100 U/ml penicillin, and 100 Ag/ml streptomycin (M 199) . The tachyzoites were counted in trypan blue, and the concentration was adjusted to 1.6 X 107/ml. I00-Ml aliquots were dispensed into individual tubes containing 100 Ml milk or IgA from either seropositive or seronegative control subjects and incubated at 37°C while rocking on a platform rocker (Bellco Biotechnology, Vineland, NJ) at 10 rpm. Sera from uninfected and infected mice (23) were also incubated with tachyzoites as described above, as internal controls in each assay. After 30 min, the volumes were adjusted to 400 Al with M199 containing 10% FCS.
In vitro challenge. whey]/cpm untreated control). In addition, enterocytes were cultured and challenged in fourchamber slides (LabTek; Nunc, Naperville, IL) as previously described for macrophages (23) , and numbers of enterocytes per field (X400), percent infected cells, and mean number of tachyzoites per vacuole were assessed as previously described (23 (25) . The T. gondii antigens resolved by SDS-PAGE were transferred to a polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA) using a semidry electroblotting apparatus (American Bionetics, Hayward, CA). The transfer buffer consisted of25 mM Tris, 40 mM 6-aminohexanoic acid, and 20% methanol, pH 9.4. A constant current of 2.5 mA/cm2 was applied for 1 h at room temperature.
To determine whether antigens were polypeptides, lipids, or carbohydrates, T. gondii antigens were also treated with proteinase K (1 U/ml; Sigma Chemical Co.) for 1 h, neuraminidase ( 1 U/ml; Sigma Chemical Co.) for 4 h, or periodate (10 nM, Sigma Chemical Co.) for 30 min and blotted as described (25) .
Western blot. Polyvinylidene difluoride membranes were blocked overnight at 4°C with 5% non-fat powdered milk in buffer (140 mM NaCl, 0.05% Tween 20, in 15 Correlation coefficients were determined by regression analysis. Differences were considered significant when P < 0.05.
Results
Secretory IgA ELISA. Whey from three of three acutely infected mothers contained T. gondii-specific secretory IgA when tested in ELISAs (Fig. 1) . ELISA values with whey from the chronically infected and seronegative women were substantially less (Fig. 1 ). There was no definitive association between concentrations of total IgA and presence of T. gondii-specific secretory IgA demonstrated by ELISA (Fig. 1) . Specifically, data in Fig. 1 indicate that two women had whey with higher amounts oftotal IgA and specific antibody to T. gondiiand two women had whey with higher amounts of total IgA and no specific antibody to T. gondii. Two of four samples with substantial total IgA had substantial specific IgA antibody to T. (Fig. 2) . Treatment of nitrocellulose strips of electrophoresed Toxoplasma antigens with periodate (10 nM) for 30 min, neuraminidase (1 U/ml) for 4 h, or protease (proteinase K) (1 U/ml) for 1 h demonstrated that all these antibodies were directed against proteins.
Enterocyte challenge. An in vitro enterocyte challenge assay was developed to determine whether these antibodies had potential biological significance in protection against T. gondii. Me49 strain tachyzoites were incubated with whey, and in subsequent experiments with jacalin-purified secretory IgA subclass 1. Whey from the initially studied acutely infected mother, and to a lesser extent whey from the initially studied chronically infected mother, inhibited replication after in vitro T. gondii challenge in a dose-dependent manner (Fig. 4) . Replication was measured as tritiated uracil uptake (Fig. 4) . These results were confirmed when whey from all 16 women were studied simultaneously ( Fig. 5 A and B) . Results were the same whether data are expressed as normalized data from replicate experiments (Fig. 5 A) or counts per minute for a single representative experiment (Fig. 5 B) .
IgA 1 was purified using a jacalin affinity column. This IgA 1 from the acutely infected mother, but not the seronegative mother, also inhibited T. gondii. Data from a representative experiment are in Fig. 6 .
Whey was not toxic to the enterocytes. There was no difference in thymidine uptake of enterocytes treated with media, women. There was a very faint band at 30 kD for subject 17, which is not seen in this photograph. There is a 30-kD doublet in subject 2's whey. Also note the 46-kD bands in whey from subjects 1, 2, 3, 17, and 7. A faint band at 46 kD was seen on the original blots for subject 6 but is not clearly seen in this photograph. whey from the seronegative mother, or whey from the acutely infected mother. This assay detected less than twofold differences in enterocyte numbers accurately. Numbers of cells per high-power field evaluated by light microscopy were not altered by incubation with the whey sample. Microscopic analysis revealed that whey diminished infection of enterocytes by T. gondii but not subsequent replication of T gondii. Specifically, in a representative experiment, in No Ab, refers to effect of media alone; o, effect of sera from seronegative mice or whey from a seronegative human mother; o, effect of sera from chronically infected mice or milk from the chronically infected mother; and ., effect of whey from the acutely infected mother.
Differences between milk from uninfected and infected individuals were significant. ENT refers to counts per minute from enterocytes in culture alone; Me49 refers to counts per minute from the Me49 strain of T. gondii in culture alone. Direct agglutination. Whey and jacalin affinity-purified secretory IgA from the two most recently infected mothers (subjects 1 and 2) agglutinated T. gondii tachyzoites. Whey from the other acutely infected mother (subject 3), who also was untreated, did not agglutinate T. gondii tachyzoites. This suggests that one mechanism of action of secretory IgA, but not the only one, could be agglutination of T. gondii.
Discussion
In earlier studies, we demonstrated that mice have intestinal IgA specific for T. gondii (26) . Whey from uninfected, chronically, and acutely infected mothers was studied to determine whether humans also have T. (Table II) .
To simulate the natural route of infection, i.e., oral ingestion of T. gondii followed by subsequent invasion of the intestinal mucosa, an enterocyte challenge assay was developed. The Me49 strain of T. gondii was adapted from its murine host to a tissue culture propagation system. The now rapidly dividing tachyzoites were used to infect rat enterocytes (22) For studies of the initial samples (Fig. 2) , antisera to secretory IgA, IgA, and secretory piece were used to demonstrate that intact secretory IgA was reactive rather thanjust IgA monomers. Antibodies to IgA 1 and IgA2 were not further differentiated by Western blotting. As jacalin isolates only subtype IgA 1, there may be other substances in whey (e.g., IgA2 or IgG) from infected women that contribute to differences in uracil incorporation.
As we have found that human whey contains a T. gondiispecific secretory IgA antibody that can reduce infection in enterocytes in vitro, it may be possible to stimulate such an antibody in vivo. This could then contribute to protection against peroral acquisition of T. gondii. There are a number of other examples of pathogen-specific IgA in milk ( 17, 18) and protection provided by sIgA or milk that presumably contains such IgA (3-7, 16, 18) , as well as protection against certain pathogens (e.g., polio virus) conferred by oral immunization. The studies described herein, as well as work with other microorganisms (3) (4) (5) (6) (7) (16) (17) (18) , provide a rationale for future studies to determine whether such T. gondii-specific IgA antibody also protects in vivo. They provide a basis to further characterize the T. gondii epitope(s) that stimulate(s) such protective antibody and to determine whether intestinal immunization (27) can protect against acquisition of T. gondii.
